請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57497
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 游若? | |
dc.contributor.author | Chih-Yu Chang | en |
dc.contributor.author | 張志宇 | zh_TW |
dc.date.accessioned | 2021-06-16T06:48:40Z | - |
dc.date.available | 2019-08-08 | |
dc.date.copyright | 2014-08-08 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-07-24 | |
dc.identifier.citation | 林錦淡。1983。啤酒釀造技術。華香園出版社。臺北。
藝軒編輯部。1993,道氏醫學大辭典。藝軒圖書出版社。臺北。 廖建俐。2006。利用巨噬細胞株膜式探討豆奶與發酵豆奶對發炎反應之影響。國立臺灣大學 生物資源暨農學院食品科技研究所碩士論文。臺北。 賴俍瑋。2013。數株Saccharomyces cerevisiae 及其區分物抑制大腸癌細胞增生及大腸細胞株 抗細胞毒性研究。國立臺灣大學生物資源暨農學院食品科技研究所碩士論文。臺北。 行政院衛生署。2013。歷年癌症主要死亡原因統計。行政院衛生署。臺北。臺灣。 Ames, B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983, 221, 1256-1264 Arend, W. P. Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. The Journal of clinical investigation 1991, 88, 1445-1451. Apostolopoulos, V.; Pietersz, G. A.; Loveland, B. E.; Sandrin, M. S.; McKenzie, I. F. Oxidative/reductive conjugation of mannan to antigen selects for t1 or t2 immune responses. Proceedings of the National Academy of Sciences of the United States of America 1995, 92, 10128-10132. Arruda, D. C.; Santos, L. C.; Melo, F. M.; Pereira, F. V.; Figueiredo, C. R.; Matsuo, A. L.; Mortara, R. A.; Juliano, M. A.; Rodrigues, E. G.; Dobroff, A. S.; Polonelli, L.; Travassos, L. R. Beta-actinbinding complementarity-determining region 2 of variable heavy chain from monoclonal antibody c7 induces apoptosis in several human tumor cells and is protective against metastatic melanoma. The Journal of biological chemistry 2012, 287, 14912-14922. Bacon, W.; Cherms, F. L.; Macdonald, G. J.; McShan, W. H. Gonadotropin potency variation in anterior pituitaries from sexually amature male quail (coturnix japonica). Poultry science 1969, 48, 718-721. Balk, E. M.; Tatsioni, A.; Lichtenstein, A. H.; Lau, J.; Pittas, A. G. Effect of chromium supplementation on glucose metabolism and lipids: A systematic review of randomized controlled trials. Diabetes care 2007, 30, 2154-2163. Balkwill, F.; Mantovani, A. Inflammation and cancer: Back to virchow? The Lancet 2001, 357, 539- 545. Bedenne, L.; Faivre, J.; Boutron, M. C.; Piard, F.; Cauvin, J. M.; Hillon, P. Adenoma--carcinoma sequence or 'de novo' carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer 1992, 69, 883-888. Bland, E. J.; Keshavarz, T.; Bucke, C. The influence of small oligosaccharides on the immune syst em. Carbohydrate research 2004, 339, 1673-1678. Blasco, L.; Veiga-Crespo, P.; Sanchez-Perez, A.; Villa, T. G. Cloning and characterization of the beer foaming gene cfg1 from Saccharomyces pastorianus. Journal of agricultural and food chemistry 2012, 60, 10796-10807. Cameron, D. R.; Cooper, D. G.; Neufeld, R. J. The mannoprotein of saccharomyces cerevisiae is an effective bioemulsifier. Applied and environmental microbiology 1988, 54, 1420-1425. Casey, G. P.; Magnus, C. A.; Ingledew, W. M. High-gravity brewing: Effects of nutrition on yeast composition, fermentative ability, and alcohol production. Applied and environmental microbiology 1984, 48, 639-646. Chaka, W.; Verheul, A. F.; Vaishnav, V. V.; Cherniak, R.; Scharringa, J.; Verhoef, J.; Snippe, H.; Hoepelman, I. M. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infection and immunity 1997, 65, 272-278. Chen, Y. C.; Shen, S. C.; Chen, L. G.; Lee, T. J.; Yang, L. L. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochemical pharmacology 2001, 61,1417-1427. Cohen, J. The immunopathogenesis of sepsis. Nature 2002, 420, 885-891. de Silva GK, Jayamaha JM, Gabriel A. Pattern and prevalence of oral carcinoma in a surgical unit at Cancer Institute Maharagama. Ceylon Med J 1995, 40(4): 146-7. Di Luzio, N.R.; McNamee, R.; Browder, I.Wo; Williams, D.L.: Glucan: Inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models. Cancer treat. 1978, 62, 1857-1866. Di Luzio, N. R.; Williams, D. L.; Sherwood, E. R.; Browder, I. W. Modification of diverse experimental immunosuppressive states by glucan. Survey of immunologic research 1985, 4, 160- 167. Dinerman, J. L.; Lowenstein, C. J.; Snyder, S. H. Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease. Circulation research 1993, 73, 217-222. Doll, R. and Peto, R. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst 1981, 66, 1191-1308. Ferreira, I. M. P. L. V. O.; Pinho, O.; Vieira, E.; Tavarela, J. G. Brewer's Saccharomyces yeast biomass: Characteristics and potential applications. Trends in Food Science and Technology 2010, 21, 77-84. Ferrero-Miliani, L.; Nielsen, O. H.; Andersen, P. S.; Girardin, S. E. Chronic inflammation: Importance of nod2 and nalp3 in interleukin-1beta generation. Clinical and experimental immunology 2007, 147, 227-235. Food and Drug Administration. Specifications 194 and FDA Appendix A Food Additives. SEC 201 (s) of the FD&C Act. (1983) Freimund, S.; Sauter, M.; Käppeli, O.; Dutler, H. A new non-degrading isolation process for 1,3-β-dglucan of high purity from baker's yeast Saccharomyces cerevisiae. Carbohydrate polymers 2003, 54, 159-171. Fu, J. Y.; Masferrer, J. L.; Seibert, K.; Raz, A.; Needleman, P. The induction and suppression of prostaglandin h2 synthase (cyclooxygenase) in human monocytes. The Journal of biological chemistry 1990, 265, 16737-16740. Gow, N. A.; van de Veerdonk, F. L.; Brown, A. J.; Netea, M. G. Candida albicans morphogenesis and host defence: Discriminating invasion from colonization. Nature reviews. Microbiology 2012, 10, 112-122. Griess, J.P. Bemerkungen zu der Abhandlung der H.H. Weselsky und Benedikt, über einige Azoverbindungen. Ber. Dtsch. Chem. Ges 1879, 12, 426-428. Groden, J.; Thliveris, A.; Samowitz, W.; Carlson, M.; Gelbert, L.; Albertsen, H.; Joslyn, G.; Stevens, J.; Spirio, L.; Robertson, M.; Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66, 589-600. Gryfe, R.; Swallow, C.; Bapat, B.; Redston, M.; Gallinger, S.; Couture, J. Molecular biology of colorectal cancer. Current problems in cancer 1997, 21, 233-300. Handschin, C.; Spiegelman, B. M. The role of exercise and pgc1alpha in inflammation and chronic disease. Nature 2008, 454, 463-469. Holzapfel, W. H.; Haberer, P.; Snel, J.; Schillinger, U.; Huis in't Veld, J. H. Overview of gut flora and probiotics. International journal of food microbiology 1998, 41, 85-101. Ishida-Okawara, A.; Nagi-Miura, N.; Oharaseki, T.; Takahashi, K.; Okumura, A.; Tachikawa, H.; Kashiwamura, S.; Okamura, H.; Ohno, N.; Okada, H.; Ward, P. A.; Suzuki, K. Neutrophil activation and arteritis induced by C. albicans water-soluble mannoprotein-beta-glucan complex (caws). Experimental and molecular pathology 2007, 82, 220-226. Karpuzoglu, E.; Ahmed, S. A. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: Implications for immunity, autoimmune diseases, and apoptosis. Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2006, 15, 177-186. Klenow, S.; Glei, M.; Haber, B.; Owen, R.; Pool-Zobel, B. L. Carob fibre compounds modulate parameters of cell growth differently in human ht29 colon adenocarcinoma cells than in lt97 colon adenoma cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2008, 46, 1389-1397. Klis, F. M.; Boorsma, A.; De Groot, P. W. Cell wall construction in Saccharomyces cerevisiae. Yeast 2006, 23, 185-202. Knowles, R. G.; Moncada, S. Nitric oxide synthases in mammals. The Biochemical journal 1994, 298 ( Pt 2), 249-258. Kollar, R.; Petrakova, E.; Ashwell, G.; Robbins, P. W.; Cabib, E. Architecture of the yeast cell wall. The linkage between chitin and beta(1-->3)-glucan. The Journal of biological chemistry 1995, 270, 1170-1178. Konno, Y.; Takahashi, S.; Naruse, R.; Mikami, T.; Matsumoto, T.; Suzuki, S.; Suzuki, M. Antimetastatic effect of yeast mannan-bleomycin conjugate against mouse lewis lung carcinoma. Biological and pharmaceutical bulletin 1994, 17, 748-752. Krizkova, L.; Zitnanova, I.; Mislovicova, D.; Masarova, J.; Sasinkova, V.; Durackova, Z.; Krajcovic, J. Antioxidant and antimutagenic activity of mannan neoglycoconjugates: Mannan-human serum albumin and mannan-penicillin g acylase. Mutation research 2006, 606, 72-79. Kurtzman, C. P.; Robnett, C. J. Phylogenetic relationships among species of Saccharomyces, Schizosaccharomyces, Debaryomyces and Schwanniomyces determined from partial ribosomal rna sequences. Yeast 1991, 7, 61-72. Lancaster, J. R., Jr. Diffusion of free nitric oxide. Methods in enzymology 1996, 268, 31-50. Lavi, I.; Friesem, D.; Geresh, S.; Hadar, Y.; Schwartz, B. An aqueous polysaccharide extract from the edible mushroom pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on ht- 29 colon cancer cells. Cancer Lett 2006, 244, 61-70. Lesage, G.; Bussey, H. Cell wall assembly in Saccharomyces cerevisiae. Microbiology and molecular biology reviews: MMBR 2006, 70, 317-343. Li, G.; Kim, D. H.; Kim, T. D.; Park, B. J.; Park, H. D.; Park, J. I.; Na, M. K.; Kim, H. C.; Hong, N. D.; Lim, K.; Hwang, B. D.; Yoon, W. H. Protein-bound polysaccharide from Phellinus linteus induces g2/m phase arrest and apoptosis in sw480 human colon cancer cells. Cancer Lett 2004, 216, 175-181. Liu, H. Z.; Wang, Q.; He, Y. Immunoactivities and antineoplastic activities of Saccharomyces cerevisiae mannoprotein. Carbohydrate polymers 2011, 83, 1690-1695. Liu, J.; Gunn, L.; Hansen, R.; Yan, J. Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Experimental and molecular pathology 2009, 86, 208-214. Machado, M. D., Janssens, S., Soares, H. M., & Soares, E. V. Removal of heavy metals using a brewer’s yeast strain of Saccharomyces cerevisiae: Advantages of using dead biomass. Journal of applied microbiology 2009, 106, 1792-1804. MacMicking, J.; Xie, Q. W.; Nathan, C. Nitric oxide and macrophage function. Annual review of immunology 1997, 15, 323-350. McMahon, S. B.; Cafferty, W. B.; Marchand, F. Immune and glial cell factors as pain mediators and modulators. Experimental neurology 2005, 192, 444-462. Minghetti L. 2004. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63: 901-910. Morrissette, N.; Gold, E.; Aderem, A. The macrophage--a cell for all seasons. Trends in cell biology 1999, 9, 199-201. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of immunological methods 1983, 65, 55-63. Nguyen, T. H.; Fleet, G. H.; Rogers, P. L. Composition of the cell walls of several yeast species. Applied microbiology and biotechnology 1998, 50, 206-212. Ohkuma, S.; Katsura, M. Nitric oxide and peroxynitrite as factors to stimulate neurotransmitter release in the cns. Progress in neurobiology 2001, 64, 97-108. Omaetxebarria, M. J.; Moragues, M. D.; Elguezabal, N.; Rodriguez-Alejandre, A.; Brena, S.; Schneider, J.; Polonelli, L.; Ponton, J. Antifungal and antitumor activities of a monoclonal antibody directed against a stress mannoprotein of Candida albicans. Current molecular medicine 2005, 5, 393-401. Ostergaard, S.; Olsson, L.; Nielsen, J. Metabolic engineering of Saccharomyces cerevisiae. Microbiology and molecular biology reviews 2000, 64, 34-50. Perjesi, P.; Das, U.; De Clercq, E.; Balzarini, J.; Kawase, M.; Sakagami, H.; Stables, J. P.; Lorand, T.; Rozmer, Z.; Dimmock, J. R. Design, synthesis and antiproliferative activity of some 3- benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. European journal of medicinal chemistry 2008, 43, 839-845. Pietrella, D.; Cherniak, R.; Strappini, C.; Perito, S.; Mosci, P.; Bistoni, F.; Vecchiarelli, A. Role of mannoprotein in induction and regulation of immunity to cryptococcus neoformans. Infection and immunity 2001, 69, 2808-2814. Posadas, S. J.; Caz, V.; Caballero, I.; Cendejas, E.; Quilez, I.; Largo, C.; Elvira, M.; De Miguel, E. Effects of mannoprotein e1 in liquid diet on inflammatory response and tlr5 expression in the gut of rats infected by Salmonella typhimurium. BMC gastroenterology 2010, 10, 58. Poutsiaka, D. D.; Clark, B. D.; Vannier, E.; Dinarello, C. A. Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. Blood 1991, 78, 1275-1281. Qiao, Y.; Bai, X. F.; Du, Y. G. Chitosan oligosaccharides protect mice from lps challenge by attenuation of inflammation and oxidative stress. International immunopharmacology 2011, 11, 121-127. Raetz, C. R. Biochemistry of endotoxins. Annual review of biochemistry 1990, 59, 129-170. Ruiz, N.; Kahne, D.; Silhavy, T. J. Transport of lipopolysaccharide across the cell envelope: The long road of discovery. Nature reviews. Microbiology 2009, 7, 677-683. Schlecht NF, Franco EL, Pintos J, Negassa A, Kowalski LP, Oliveira BV. Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aero-digestive tract in Brazil. Am J Epidemiol 1999, 150, 1129-1137. Schrauzer, G. N. Selenium yeast: Composition, quality, analysis, and safety. Pure and Applied Chemistry 2006, 78, 105-109. Schwarz, K., Mertz, W. Chromium (III) and the glucose tolerance factor. Archives of Biochemistry and Biophysics 1959, 85, 292-295. Scott, S.; McGurk, M.; Grunfeld, E. Patient delay for potentially malignant oral symptoms. European journal of oral sciences 2008, 116, 141-147. Selvaraj, V.; Sampath, K.; Sekar, V. Administration of yeast glucan enhances survival and some non-specific and specific immune parameters in carp (Cyprinus carpio) infected with aeromonas hydrophila. Fish and shellfish immunology 2005, 19, 293-306. Shimada K, Fujikawa K, Yahara K, Nakamura T. Antioxidative properties of xanthan on anti-oxidation of soybean oil in cyclodextrin emulsion. J Agric Food Chem 1992, 40, 945-948. Slameova, D., La´baj, J., Krizˇkova, L., Kogan, G., Sandula, J., Bresgen, N., Eckl, P. Protective effects of fungal (1→3)-β-glucan derivatives against oxidative DNA lesions in v79 hamster lung cells. Cancer Letters 2003, 198, 153-160. Soltys, J.; Quinn, M. T. Modulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan. Infection and immunity 1999, 67, 244-252. Sreejayan; Rao, M. N. Nitric oxide scavenging by curcuminoids. The Journal of pharmacy and pharmacology 1997, 49, 105-107. Surh, Y. J. Cancer chemoprevention with dietary phytochemicals. Nature reviews. Cancer 2003, 3, 768-780. Takeshige, K.; Ouchi, K., Reconstruction of ethanol fermentation in permeabilized cells of the yeast Saccharomyces cerevisiae. J Ferment Bioeng 1995, 79, 11-16. Tilg, H.; Trehu, E.; Atkins, M. B.; Dinarello, C. A.; Mier, J. W. Interleukin-6 (il-6) as an antiinflammatory cytokine: Induction of circulating il-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83, 113-118. Tzianabos, A. O. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clinical Microbiology Reviews 2000, 13, 523-533. Vecchiarelli, A.; Puliti, M.; Torosantucci, A.; Cassone, A.; Bistoni, F. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cellular immunology 1991, 134, 65-76. Volman, J. J.; Ramakers, J. D.; Plat, J. Dietary modulation of immune function by beta-glucans. Physiology and behavior 2008, 94, 276-284. Wang, F.; Le, G. W.; Shi, Y. H.; Chen, Z. S. Effect of mannose-oligosaccharides on scavenging free redicals and the activities of antioxidant enzymes in liver of rats. Journal of Anhui Agri 2007, 29(5), 466-469. Waters, E. J.; Pellerin, P.; Brillouet, J. M. A wine arabinogalactan-protein that reduces heat-induced wine protein haze. Bioscience, biotechnology, and biochemistry 1994, 58, 43-48. Xu, X.; Yasuda, M.; Mizuno, M.; Ashida, H. Beta-glucan from Saccharomyces cerevisiae reduces lipopolysaccharide-induced inflammatory responses in raw264.7 macrophages. Biochimica et biophysica acta 2012, 1820, 1656-1663. Yermilov, V.; Rubio, J.; Ohshima, H. Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett. 1995, 376, 207-210. Yoon, T. J.; Kim, T. J.; Lee, H.; Shin, K. S.; Yun, Y. P.; Moon, W. K.; Kim, D. W.; Lee, K. H. Antitumor metastatic activity of beta-glucan purified from mutated Saccharomyces cerevisiae. International immunopharmacology 2008, 8, 36-42. Yoshizumi, M.; Perrella, M. A.; Burnett, J. C.; Lee, M. E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulation research 1993, 73, 205-209. Zhang, M.; Chiu, L. C.; Cheung, P. C.; Ooi, V. E. Growth-inhibitory effects of a beta-glucan from the mycelium of poria cocos on human breast carcinoma mcf-7 cells: Cell-cycle arrest and apoptosis induction. Oncology reports 2006, 15, 637-643. Zhu H, Liu H, Yan J, Wang R, Liu L. Effect of yeast polysaccharide on some hematologic parameter and gut morphology in channel catfish (Ictalurus punctatus). Fish Physiol Biochem 2012, 38, 1441-1447. Zlotnik, H.; Fernandez, M. P.; Bowers, B.; Cabib, E. Saccharomyces cerevisiae mannoproteins form an external cell wall layer that determines wall porosity. Journal of bacteriology 1984, 159, 1018- 1026. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57497 | - |
dc.description.abstract | 發炎反應為人體受傷或抵禦外來微生物時之重要免疫反應,當人體處在發炎狀態時,一些發炎相關因子將會大量生成,若過度表現對人體為一種傷害。根據行政院衛生署統計資料顯示,2012 年十大癌症死因中,大腸癌及口腔癌分別佔據第三名和第五名。酵母菌的應用廣
泛,日常生活中常用來發酵啤酒等大宗發酵產品。本研究目的係以本實驗室所保有的五株S.cerevisiae 為材料,將其進行高溫高壓蒸汽蒸煮後,分別進一步製備成酵母菌細胞壁粗區分物crude mannoprotein (CM) 和crude β-glucan (CB),於LPS 誘導RAW 264.7 巨噬細胞模式之下,是否具有降低發炎情形,及抑制腫瘤細胞HSC-3、HT-29 增生的能力。結果顯示,S.cerevisiae BCRC 21447 之CM 在濃度1000 μg/ml 時,降低LPS 誘導RAW 264.7 分泌NO 含 量為五株酵母菌最多,相對LPS 組下降14.79%,而CB 在200 μg/ml 時,五株酵母菌皆有顯著性降低NO 含量( p < 0.05 ),其中又以S.cerevisiae BCRC 1599 ( 21.27% ) 效果最佳。此外CM 在濃度1000 μg/ml 時,具有較佳的清除DPPH 和NO 之能力,於西方墨點法的結果顯示,S. cerevisiae BCRC 21812 和S. cerevisiae BCRC 21447 之CB 可明顯隨著濃度增加而降低iNOS 蛋白質表現量,此外,五株酵母菌之CM 在濃度為125μg/ml 時能降低TNF-α 含量達顯著性差異( p < 0.05 ),而CB 在200 μg/ml 濃度下均顯著降低TNF-α 和IL-6 之生成量,在濃度100 μg/ml 以上時,也均顯著降低IL-1β 之生成量。最後,五株酵母菌細胞壁粗區分物CM和CB 對於兩株腫瘤細胞HSC-3、HT-29 具有抑制增生功效,如1000 μg/ml 的S.cerevisiae BCRC 21447 之CM 處理HSC-3 cell ,其存活率為60.94%;200 μg/ml 的CB 為70.42%。而 1000 μg/ml 的S. cerevisiae BCRC 21447 之CM 處理HT-29 cell ,其存活率為73.52%;200μg/ml 的CB 為75.49%。綜合上述結果,酵母菌細胞壁粗區分物CM 和CB 具有抗發炎和抑制HSC-3 ( oral ) and HT-29 ( colon ) 這兩株腫瘤細胞增生之功效。 | zh_TW |
dc.description.abstract | Inflammation is an important human immune response against foreign microorganisms. When the body in a state of inflammation will generate some inflammatory factors. Department of Health (2013) statistics showed that cancer has been the first reason causes of death. Colon cancer and oral cancer occupy third place and five place of death of cancer in 2012. Saccharomyces cerevisiae is not only an excellent source of protein but also a functional food as probiotics. Another application of S.cerevisiae is used to ferment beer, wine or bread. The objective of this study was to investigate effects of crude cell wall fractions of several S. cerevisiae on LPS-induced RAW 264.7 macrophages. In addition, the DPPH, NO scavenging of crude cell wall fractions. Furthermore, the anti-proliferation of tumor cells of the crude cell wall fractions of several S. cerevisiae. The result revealed that both of crude mannoprotein (CM) and crude β-glucan (CB) suppressed production of NO. The highest inhibition ability followed by 1000 μg/ml CM from S. cerevisiae BCRC 21447 (85.21%, compare to LPS group) and 200 μg/ml CB from S. cerevisiae BCRC 1599 (78.73%, compare to LPS group). CM showed the better DPPH and NO scavenging activity than CB. Western blot analyses revealed that CB of S. cerevisiae inhibited protein expression of iNOS in LPS-induced macrophage; especially, S. cerevisiae BCRC 21812 and 21447. Also, 200 μg/ml CB of S. cerevisiae BCRC 21447 reduced TNF-α from 24.71 ± 1.09 ng/ml to 3.06 ± 0.15 ng/ml. All of the crude cell wall fractions lowered the production of IL -1β, IL-6 in high concentration. Moreover, these crude cell wall fractions of several S. cerevisiae showed various degree of the inhibitory effect on anti-proliferation of HSC-3, HT-29
tumor cells. 1000 μg/ml CM of S. cerevisiae BCRC 21447 inhibited survival rate of HSC-3 cells by 60.94%, 200 μg/ml CB inhibited survival rate of HSC-3 cells by 70.42%. 1000 μg/ml CM of S. cerevisiae BCRC 21447 inhibited survival rate of HT-29 cells by 73.52%, 200 μg/ml CB inhibited survival rate of HSC-3 cells by 75.49%. Conclusively, both CM and CB had anti-inflammatory activity and anti-proliferative activity of oral and colon cancer cell line. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T06:48:40Z (GMT). No. of bitstreams: 1 ntu-103-R01641028-1.pdf: 2590524 bytes, checksum: 51c5b005b0491e13d9a24c7484746924 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 目錄
誌謝.................................................I 摘要.................................................II Abstract .............................................III 目錄..................................................IV 圖目錄...............................................VII 表目錄............................................... IX 壹、前言............................................. 1 貳、文獻整理....................................... 3 一、酵母菌............................................ 3 (一) 酵母菌之特性 ...................................... 3 (二) 酵母菌之益生作用 ............................. 4 (三) 酵母菌之應用 .................................. 4 (四) Saccharomyces cerevisiae ..................... 6 二、Saccharomyces cerevisiae 細胞壁 ................. 7 (一) Saccharomyces cerevisiae 細胞壁之組成及結構 ..... 7 (二) Saccharomyces cerevisiae 細胞壁之功能性 ........ 11 三、發炎反應與相關因子.................................. 13 (一) 發炎反應 ............................... 13 (二) 巨噬細胞............................................ 13 (三) 脂多醣及誘導巨噬細胞活化 ..................... 14 (四) 發炎相關因子 ...................................... 16 四、癌症............................ 20 (一) 飲食與癌症 ...................................... 20 (二) 口腔癌 ....................................... 22 (三) 大腸癌 ............................................ 23 参、實驗架構..................................... 24 肆、材料與方法...................................... 27 一、實驗材料............................................ 27 (一) 試驗菌株 .................................. 27 (二) 試驗細胞株 ........................... 27 (三) 培養基 ......................................... 27 (四) 化學藥品及試劑 ........................... 28 二、儀器設備............................................31三、實驗方法.................................... 32 (一) 酵母菌的保存與活化 .................. 32 (二) 製備酵母菌細胞壁粗區分物 .............. 33 (三) 細胞株之活化、繼代培養與保存 ...... 34 (四) MTT 細胞存活率分析.................................. 35 (五) NO 含量測定( Griess assay ).............. 36 (六) 清除DPPH 自由基活性測定 ................... 37 (七) 清除NO 能力測定 .................................. 37 (八) Western blotting 西方墨點法– iNOS 及COX-2 蛋白質表現 ................................. 38 (九) 促發炎細胞激素測定 ...................... 40 (十) 統計分析 ....................................... 41 伍、結果與討論......................................... 42 一、酵母菌細胞壁粗區分物產量.............. 42 二、酵母菌細胞壁粗區分物對RAW 264.7 之細胞毒性 .......... 45 三、酵母菌細胞壁粗區分物對LPS 誘導RAW 264.7 分泌NO 含量之影響 ........................ 51 四、酵母菌細胞壁粗區分物清除DPPH 自由基之能力 .......... 55 五、酵母菌細胞壁粗區分物清除NO 之能力 ......... 58 六、酵母菌細胞壁粗區分物對iNOS 及COX-2 蛋白質表現 ................................................. 62 (一) Saccharomyces cerevisiae HP01 之酵母菌細胞壁粗區分物對RAW 264.7細胞iNOS 及COX-2 蛋白質表現之影響 ................................................................ 62 (二) Saccharomyces cerevisiae BCRC 21812 之酵母菌細胞壁粗區分物對RAW 264.7 細胞iNOS 及COX-2 蛋白質表現之影響 ............................................ 62 (三) Saccharomyces cerevisiae BCRC 21447 之酵母菌細胞壁粗區分物對RAW 264.7 細胞iNOS 及COX-2 蛋白質表現之影響 ............................................ 63 (四) Saccharomyces cerevisiae MB08 之酵母菌細胞壁粗區分物對 RAW 264.7 細胞iNOS 及COX-2 蛋白質表現之影響 ............................................ 64 (五) Saccharomyces cerevisiae BCRC 1599 之酵母菌細胞壁粗區分物對RAW 264.7 細胞iNOS 及COX-2 蛋白質表現之影響 ............................................ 64 七、酵母菌細胞壁粗區分物對促發炎細胞激素生成之影響.................................................. 71 (一)酵母菌細胞壁粗區分物對LPS 誘導RAW 264.7 細胞生成TNF-α 影響 ................ 71 (二)酵母菌細胞壁粗區分物對LPS 誘導RAW 264.7 細胞生成IL-6 影響 .................... 75 (三)酵母菌細胞壁粗區分物對LPS 誘導RAW 264.7 細胞生成IL-1β 影響 .................. 75 八、酵母菌細胞壁粗區分物對數株腫瘤細胞存活率之影響.................................................. 81 (一) 酵母菌細胞壁粗區分物對HSC-3 腫瘤細胞存活率之影響 .................................... 81 (二) 酵母菌細胞壁粗區分物對HT-29 腫瘤細胞存活率之影響..................................... 84 陸、結論....................... 88 柒、參考文獻...................... 90 | |
dc.language.iso | zh-TW | |
dc.title | 數株Saccharomyces cerevisiae 細胞壁粗區分物之抗發炎及抑制腫瘤細胞增生功效研究 | zh_TW |
dc.title | Anti-inflammatory activity and Anti-proliferation of tumor cells by the crude cell wall fractions of several Saccharomyces cerevisiae strains | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 丘志威,蔡國珍,周正俊,潘崇良 | |
dc.subject.keyword | 發炎,癌症,酵母菌細胞壁,巨噬細胞,iNOS 蛋白質, | zh_TW |
dc.subject.keyword | Inflammation,cancer,cell wall fractions of several S. cerevisiae,RAW 264.7,iNOS, | en |
dc.relation.page | 99 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-07-24 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 2.53 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。